Clinical efficacy and safety of FP-7 Ahmed glaucoma valve implantation in neurovascular glaucoma patients
Document Type
Article
Publication Date
10-1-2011
Abstract
Objective: To evaluate the efficacy and safety of FP-7 Ahmed glaucoma valves (AGV) implantation in neurovascular glaucoma (NVG) as the first choice of surgery. Methods: This retrospective, comparative case series study collected a total of 36 eyes of 36 patients with neurovascular glaucoma who underwent AGV implantation in Zhongshan Ophthalmic Center from January 2009 to June 2010. hange of intraocular pressure (IOP), the best corrected visual acuity, numbers of anti-glaucoma medication, success rate and postoperative complications were followed up at day 1, week 1, month 1, and every 3 months after surgery. Complete success of surgery was rated as reduction of IOP ≥30% without medication and those who failed to meet criteria was rated as partial success. Data were analyzed by paired Student t-test for IOP, rank sum test for paired non-parametric numbers of medication, and repeated measures analysis of variance for comparison of IOP between different time points using SPSS 13.0. Results: Compared with pre-operation, IOP was significant (F=9.26, P<0.05) decreased after surgery with FP-7 AGV implantation (39.5±9.7) mm Hg(1 mm Hg=0.133 kPa)vs(9.2±8.9), (11.8±3.8), (13.7±4.8), (16.9±5.3), (16.9±6.8) mm Hg at day 1, week 1, month 1, month 3 and the last following-up of post-operation, respectively. The numbers of anti-glaucoma medication were significantly (Z=6.764, P<0.05) reduced from 4.0(1-6) of pre-operation to 1.0 (1-3) of post-operation. At the last following up, the complete success rate after FP-7 AGV implantation was 80.6%, and qualified success rate was 91.7%. The postoperative complications including occlusion of the drainage tube, exposure of the drainage tube, shallow anterior chamber and encapsulated cystic blebs around the plate were controlled with additional treatment. Conclusions: The clinical outcome indicated that the implantation of FP-7 AGV has a stable IOP lowering effect and fewer complications, which can be considered as one of the first choices for management of NVG.
Publication Source (Journal or Book title)
Chinese Journal of Ophthalmology
First Page
893
Last Page
897
Recommended Citation
Bai, Y., Wang, M., Li, Y., Chai, F., Wei, Y., Zhang, Y., Yang, X., Ge, J., & Zhuo, Y. (2011). Clinical efficacy and safety of FP-7 Ahmed glaucoma valve implantation in neurovascular glaucoma patients. Chinese Journal of Ophthalmology, 47 (10), 893-897. https://doi.org/10.3760/cma.j.issn.0412-4081.2011.10.007